Form 8-K · Current report
Illumina, Inc. 8-K, filed Aug 12, 2026
- Filed
- CIK
- 0001110803
- Accession no.
- 0001193125-26-345802
Summary
Illumina, Inc. entered into an underwriting agreement with J.P. Morgan Securities LLC and Citigroup Global Markets Inc. as representatives of the underwriters for the sale of $300 million aggregate principal amount of 4.950% notes due 2029, with the offering expected to close on August 17, 2026. Illumina expects to use the net proceeds together with cash on hand to repay its 4.650% notes due September 9, 2026.
Key points
- The underwriting agreement was dated August 10, 2026, and covers $300,000,000 aggregate principal amount of 4.950% notes due 2029.
- The offering is expected to close on August 17, 2026, subject to customary closing conditions.
- Net proceeds, together with cash on hand, are expected to repay Illumina's 4.650% notes due September 9, 2026.
- The notes are to be issued under Illumina's Form S-3 registration statement filed with the SEC on September 4, 2024.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01. Other Events. On August 10, 2026, Illumina, Inc. (“Illumina”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as representatives of the several underwriters named therein, for the issuance and sale by Illumina of $300,000,000 aggregate principal amount of its 4.950% notes due 2029 (the “Notes”). The offering is expected to close on August 17, 2026, subject to customary closing conditions. Illumina expects to use the net proceeds from the offering, together with cash on hand, to repay its 4.650% notes due September 9, 2026. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.